1Meade TW, Mellow S, Brovozic M, et al. Haemostatic function and ischaemic heart disease: principal results of the northwick park heart study[J]. Lancet,1986,2 :533- 537
2Kanell WB, Wolf PA, Castelli WP, et aL Fibrinogen and risk of cardiovascular disease; the framingham study[J]. JAMA, 1987,258:1183 - 1186
3Wilhelmsen L, Svardsudd K, Korsan Bengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction[J]. N Engl J Med,1984,311,501 - 505
4Bara L, Nicaud V, Tiret L, et al. Expression of a paternal history of premature myocardial infarction on fibrinogen, factor Vllc and PAI21 in European offspring: the EARS study[J]. Thromb haemost,1994,71,434 - 440
5Yu S, Sher B, Kudryk B, et al. Fibrinogen precursors: order of assembly of fibrinogen chains[J]. J Bio Chem, 1984,259:10574 - 10581
6BehagueI,Poirier O, Nicaud V, et al. Bfibrinogen gene polymorphismsare associated with plasma fibrinogen and coronary artery disease in patients with myocardialin - farction[J]. The ECTIM Study. Circulation, 1996,93 : 440 - 449
7Carter AM,Catto AJ, Bamford JM, et al. Gender- specific associations of the fibrinogen B beta 448 polymorphism, fibrinogen levels and acute cerebrovascular disease[J]. Arterioscler Thromb Vasc Biol,1997,17:589 - 594
8van't Hooft FM, von Bahr SJF, Silverira A,et al. Two common,functional polymorphisms in the promoter region of the beta - fibrinogen gene cotribute to regulation of fibrinogen cincentration[J]. Aterioscler Thromb Vase Biol, 1999,19 : 3063 - 3070
9Thomas AE,Green FR,Kelleher CH, et al. Variation in the promoter region of theβfibrinogen gene is associated with plasma fibrinogen levels in smokers and non - smokers[J]. Thromb Haemost, 1991,65,487 - 490
10Montgomery HE, Clarkson P, Nwose OM, et al. The a- cute risk in plasma fibrinogen concentration with exerciseis influenced by the G - 453 - Apolymorphismof the beta - fibrinogen-gene[J]. Arterioscler Thromb Vase Biol, 1996,16:386 - 391
3Samia Mora, Nader Rifai, Julie E. Buring, ct al. Additive Value of Immunoassay - Measured Fibfinogen and High - Sensitivity C - Reactive Protein Levels for Predicting Incident Cardiovascular Events[ J]. Circulation, 2006,114:381 - 387.
4Satomi Kani, Fumiko Terasawa, Kazuyoshi Yamauchi, et al. Analysis of fibrinogen variants at 38711e shows that the side chain of 387 and the tertiary structure of the C - terminal tail are important not only for assembly and secretion of fibrinogen but also for lateral aggregation of protofibrils and Xllla - catalyzed - dimer formation [J]. BLOOD, 2006, 108 (6) :1887 - 1894.
5Jennifer L. Mullin, Stephen O. Brennan, Peter S. Garlly, et al. Fibrlnogen Hillsborough: a novel Gly309Asp dysfibrinogen with impaired clotting[J]. BLOOD, 2002, 99 (10) :3597 - 3601.
6Feffrey A. Kant, Susan T. Lord, Gerald R. Crabtree. Partial mRJNA sequences for human A alpha, B beta, and gamma fibrinogen chains : evolutionary and functional implications [ J ]. Proc Nail Acad Sci, 1983, 80(13) :3953 -7.
7Margaret A. Keller, Jose Martinez, Timothy C. Baradet, et al. Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibfinogen hypereatabolism due to S378P mutation[J]. BLOOD, 2005, 105 (8) :3162 -3168.
